Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CONTRAVE® safely and effectively. See full prescribing information for CONTRAVE. CONTRAVE (naltrexone hydrochloride and bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-prescription
CONTRAVE is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Limitations of Use: The effect of CONTRAVE on cardiovascular morbidity and mortality has not been established. The safety and effectiveness of CONTRAVE in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established.
- generic_name
- naltrexone hydrochloride and bupropion hydrochloride
- product_names
- naltrexone hydrochloride and bupropion hydrochloride
- ndc
- 51267-890, 51267-890-99, 51267-890-07
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en